Weight loss drug maker sinks 25% after new safety data spooks investors

While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.

# Weight loss drug maker sinks 25% after new safety data spooks investors While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects. **Read the full article:** [CNBC](https://www.cnbc.com/2026/06/08/weight-loss-drug-stock-zealand-pharma-data-ada.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*